US Edition
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $60.73 Consensus Price Target from Analysts
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $60.73 Consensus Price Target from Analysts
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average recommendation of “Buy” by the twelve research firms that are covering the firm, Marketbeat.com reports. Ten analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year price […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
